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In the last decade, non-canonical functions have been described for several molecules with
hormone-like activities in different stages of vertebrate development. Since its puriﬁcation
in the 1960s, proinsulin has been one of the best described hormonal precursors, though
it has been overwhelmingly studied in the context of insulin, the mature protein secreted
by the pancreas. Beginning with our discovery of the presence and precise regulation of
proinsulin mRNA in early neurulation and neurogenesis, we uncovered a role for proinsulin
in cell survival in the developing nervous system.We subsequently demonstrated the abil-
ity of proinsulin to prevent pathological cell death and delay photoreceptor degeneration in
a mouse model of retinitis pigmentosa. In this review, we focus on the evolution of proin-
sulin/insulin, beginning with insulin-like peptides expressed in mainly the neurosecretory
cells of some invertebrates. We summarize ﬁndings related to the regulation of proinsulin
expression during development and discuss the possible effects of proinsulin in neural
cells or tissue, and its potential as a neuroprotective molecule.
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EVOLUTION OF INSULIN; GENE LOCI ; AND PROTEIN
Since the discovery of insulin as a metabolically essential pancre-
atic hormone by Banting and Best in 1921, this protein has been
the subject of intensive research. The overwhelming amount of
information on insulin structure and function, its receptor, and the
consequences of its dysfunction in diabetes mellitus, has overshad-
owed the importance of proinsulin, the primary product of the
insulin gene, and the protein precursor of insulin. The new roles
of proinsulin in development described by ours and other groups
(reviewed inHernández-Sánchez et al., 2006) have led to the inclu-
sion of proinsulin as a member, in its own right, of the insulin
superfamily of signaling factors,which in humans also includes the
insulin-like growth factors (IGFs)-1 and -2 and -7 members of the
relaxin-like peptides subfamily (Wilkinson and Bathgate, 2007).
This diversity indicates that the evolutionary history of insulin
began well before the appearance of the endocrine pancreas.
Proinsulin/insulin, IGFs, and related factors comprise an essen-
tial group of proteins in all metazoans, with a broad functional
spectrum, including roles in carbohydrate and lipid metabolism,
cell and organism growth, cell survival, life span, and reproduction
(Nakae et al., 2001; Taguchi and White, 2008). The insulin recep-
tor (IR) is an evolutionarily conserved member of the tyrosine
kinase class of cell membrane receptors. A closely related IGF type
1 receptor (IGFR) and an orphan insulin receptor-related recep-
tor (IRR) have been described in mammals (Hernández-Sánchez
et al., 2008), as well as an unrelated IGF type 2/Mannose-6-
phosphate receptor which binds only IGF-2. Intriguingly, despite
the antiquity of this metazoan signaling system, a greater number
of peptide ligands has been described in invertebrates, in which a
single insulin/IGF receptor has been found (up to and including
Amphioxus), than in vertebrates. Conversely, vertebrates exhibit
a greater diversity of membrane receptors (see later). Though its
functional signiﬁcance remains to be clariﬁed, an extremely well
conserved gene synteny is observed inboth vertebrates and inverte-
brates, termed the “tyrosine hydroxylase (th)–insulin cluster.” The
ancestral insulin gene (INS2) is located between th, or a related
invertebrate gene, and an adjacent gene member of the insulin
family: igf2 in vertebrates, and multiple insulin-like peptides in
invertebrates such as Drosophila melanogaster and Caenorhabditis
elegans (Figure 1).
Some of the multiple insulin-related gene products found in
lower vertebrates and invertebrates are thought to be related to
the ancestral molecule of the vertebrate insulin–IGFs. Since full
characterization of these proteins has not been reported for most
species, a few may in fact be structurally more similar to the ver-
tebrate proinsulin than to the mature pancreatic insulin. In this
review, insulin gene will be used to refer to the genomic locus and
sequence, as this is the term used in gene banks. When discussing
RNA data, we will use the term proinsulin mRNA, and for pro-
tein data we will specify whether we refer to mature insulin or
another evolutionary (insulin-like) or developmental (proinsulin)
precursor.
The D. melanogaster genome contains seven insulin-like genes
(dilp1–7 ) that are expressed in a stage-, tissue-, or cell-speciﬁc
manner (Brogiolo et al., 2001). Of these, dilp2 is the most closely
related to human insulin (35% sequence identity), while dilp6 and
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FIGURE 1 |The th/ ins gene cluster in vertebrates and invertebrates.
Schematic representation of the three genes found in conserved synteny
from birds to humans; tyrosine hydroxylase (th), insulin (ins), and insulin-like
growth factor 2 (igf2). Several insulin-like peptides are found in the genomes
of both ﬂies (D. melanogaster ) and worms (C. elegans), some of which are
located in the same region as monooxygenases. Chromosome numbers are
indicated and intergenic DNA distances are depicted in kilobases (Kb). (a) is
3079Kb and (b) is 2866Kb.
dilp7 represent the most distant relatives. Four of these genes,
dilp 1, 2, 3, and 5, are coexpressed in small clusters of cells in
larval brain neurons (Rulifson et al., 2002). As ablation of these
cells causes developmental delays,growth retardation,and elevated
carbohydrate levels in larval hemolymph, a functional analogy to
vertebrate pancreatic β cells has been proposed (Rulifson et al.,
2002). Dilp6 is expressed in the larval body fat and controlled by
the steroid hormone ecdysone duringmetamorphosis upon termi-
nationof feeding to relay the growth signal, and thus is functionally
more similar to vertebrate IGFs (Slaidina et al., 2009). Dilp7 is
found in abdominal ganglia and may play a reproductive role. Dilp
1–5 bind to the D. melanogaster single insulin/IGF receptor (33%
sequence identity with the vertebrate homologs, Fernández et al.,
1995). Recently, the crystal structure of two DILP5 variants that
differ by three amino acids at the N-terminal end of the A-chain
was described (Sajid et al., 2011). Both variants share the basic fold
of the insulin peptide family but exhibit an unusual dimeric struc-
ture. Insulin producing cells in the Drosophila brain express one of
the four known serotonin receptor signaling types (5-HT1A) and
the metabotropic receptor GABAB. The ionotropic GABAA recep-
tor subunit RDL is not expressed by these cells. Increases in DILP
expression resulting from interference with GABAB or 5-HT1A
receptor signaling shortens life span, decreases stress resistance
and alters carbohydrate, and lipid metabolism in response to stress
(Nässel and Winther, 2010).
The most important role attributed to the insulin/IR pathway
in C. elegans relates to longevity. Remarkably, the only insulin/IGF
receptor ortholog expressed by this short-lived worm, DAF-2, was
implicated in the function and evolutionary conservation of the
ﬁrst life-span pathway to be discovered (for review see Kenyon,
2010, 2011). However, much less is known about the function of
speciﬁc peptides of this family. The C. elegans genome encodes
40 putative insulin-like peptides, many of which are expressed at
low levels in whole worms. Recently, the powerful nCounter plat-
form was used to quantify insulin-like mRNA expression for all of
these peptides, revealing a variety of distinct developmental pat-
terns of expression and suggesting a considerable complexity of
regulation and speciﬁcity of function (Baugh et al., 2011). Many
of the 40 C. elegans insulin-like peptides are found in overlap-
ping subsets of sensory neurons and/or interneurons, including
the sensory neurons that regulate dauer (a diapause stage induced
in harsh environmental conditions) entry or exit. Speciﬁcally, ins-
1 mediates dauer arrest under harsh environments, while daf-28
and ins-6 ensure reproductive growth under favorable conditions.
daf-28 and ins-6 also play key roles in inhibiting dauer entry and
promoting dauer exit, respectively (Cornils et al., 2011). Taken
together, these ﬁndings indicate that insulin-like peptides have
been involved in the physiology of the nervous system since early
in evolution, a role that is highly conserved in higher vertebrates.
PROINSULIN TRANSCRIPTS IN DEVELOPMENT AND
PROINSULIN STRUCTURE
Proinsulin was isolated in the 1960s by the group of Steiner et al.
(1990), and was initially considered a low metabolic activity pro-
tein precursor of insulin. Basedonour studies of insulin expression
early in development, particularly in the embryonic chick ner-
vous system, we discovered proinsulin to be the ﬁnal protein
form secreted by extrapancreatic tissues (De Pablo et al., 1990;
Hernández-Sánchez et al., 1995, 2002). While the pancreatic reg-
ulation of proinsulin mRNA expression was initially considered
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highly tissue-speciﬁc (Steiner et al., 1990), our discovery of a series
of proinsulin transcripts in the chick embryo during prepancreatic
development challenged the view of the pancreas as an exclusive
source of proinsulin (Figure 2). The ancestral insulin gene (only
one gene is found in most of the vertebrate genomes including
chick, whereas mouse, rat, and Xenopus express two non-allelic
genes) contains three exons. The open reading frame spans most
of exon 2 and all of exon 3, coding for the B, C, and A domains of
proinsulin (Figure 2). It is plausible that the control of cell survival
in embryos requires the subtle regulation of proinsulin expression
in a different manner to that characteristic of the β cells of the
vertebrate pancreas. We characterized a speciﬁc embryonic form
of proinsulin mRNA (pro1B) with a 32 nucleotide extension in the
5′ UTR which shared its coding region with the pancreatic tran-
script (Pro1A). However, the embryonic transcript exhibits much
lower translational activity due to the presence of two extra AUGs
in the 32-nucleotide 5′-extension (Figure 3; Hernández-Sánchez
et al., 2003). We subsequently identiﬁed an additional embryonic
proinsulin mRNA generated by the retention of the ﬁrst intron in
the 5′ UTR. This large, structured 5′ UTR almost blocks proinsulin
translation,whereasmRNA transport and cytoplasmic stability are
unaffected (Mansilla et al., 2005). The relative proportion of these
transcripts varied in developing organs (see later and Figure 3),
indicating a signiﬁcant level of post-transcriptional control of the
insulin gene during vertebrate development.
Detailed screening of embryonic proinsulin transcripts ledus to
another unexpected ﬁnding: both chick and quail embryos express
chimericmRNAs containing exons fromboth th and insulin genes,
transcribed in a regulated manner (Figure 2; Hernández-Sánchez
et al., 2006). The TH-INS1 and TH-INS2 chimeras differ in their
insulin gene content, and encode two novel isoforms of the TH
protein with markedly reduced functionality, as compared with
canonical TH. In addition, TH-INS1 chimeric mRNA generates a
small amount of proinsulin/insulin. At least TH-INS1 is found
in the neurulating embryo and in the substantia nigra of the
embryonic day (E) 18 chick embryo, though its function remains
unknown. insulin–igf2 chimeric mRNAs have also been described
in the human fetal eye and pancreas, which do not produce
proinsulin (Monk et al., 2006).
The basic fold shared by known members of the insulin super-
family consists of a B domain containing a single α-helix that
lies across the two α-helices of the A domain (Murray-Rust
et al., 1992). Two canonical disulﬁde bridges connect the A-
and B-chains, while the A-chain contains an intrachain disul-
ﬁde bridge. The C-peptide is cleaved out in mature pancreatic
insulin (Figure 2B). As proinsulin is refractory to crystallization,
heteronuclear NMR spectroscopy has been employed to charac-
terize a monomeric analog. It has been proposed that ﬂexibility
at each C-domain junction facilitates prohormone processing by
convertases (Figure 2C; Yang et al., 2010). We demonstrated that
FIGURE 2 | Diversity of proinsulin transcripts and chimeric transcripts in
chick embryos. (A)The canonical th and the pancreatic proinsulin mRNAs
(Pro1A) are shown in the top panel. Below are alternative transcripts found in
embryos, either chimeric mRNAs (TH-INS1,TH-INS2) or proinsulin mRNAs
with an extended 5′ UTR (Pro1B and Pro1B1). The translation initiation codon
(AUG) and additional AUGs are indicated (modiﬁed from Hernández-Sánchez
et al., 2006). The (B,C,A) protein domains of proinsulin are marked. E, exon.
(B) Schematic representation of the amino acid composition of proinsulin and
insulin after C-peptide cleavage. (C) Structural model of proinsulin. The ribbon
rendered backbone highlights the conformational variability of the
NMR-resolved human-proinsulin, based onYang et al. (2010). The B-chain
(green), A-chain (cyan), and the C-peptide (red) are depicted before proinsulin
processing. The model (courtesy of Mario García-de Lacoba, CIB, CSIC)
demonstrates the great conformational ﬂexibility of the C-peptide.
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FIGURE 3 | Regulated splicing pattern of embryonic proinsulin mRNA.
(A) Stage 10 chick embryo (approximately 36 h of development) with the
dotted line indicating the embryonic heart (H); the presomitic region (PS),
and optic vesicle (OV) are depicted. (B) Proinsulin reverse transcription-PCR
followed by Southern blot of RNA from different regions of stage 10
embryos. Intron 1 is retained in the Pro1B1 transcript, but spliced out in
Pro1B. The latter form predominates in the OV (largely neuroepithelium at
this stage) and is relatively less abundant in other embryonic regions. (C)
Proinsulin expression in NIH3T3 cells transfected with the indicated
construct. Modiﬁed from Mansilla et al. (2005).
proinsulin remains unprocessed in the neurulating chick embryo
and the neuroretina due to the lack of expression of at least one of
the proinsulin convertases, PC2 (Alarcón et al., 1998; Hernández-
Sánchez et al., 2002). Neural proinsulin is likely to be secreted by
a constitutive secretory pathway. In cultured neuroretina, rapid
secretion of proinsulin into the medium occurred within a few
hours, even in the absence of secretagogues (Hernández-Sánchez
et al., 1995).
REGULATION OF PROINSULIN EXPRESSION IN EARLY
DEVELOPMENT
Prepancreatic and extrapancreatic proinsulin mRNA expression is
much lower than that observed in the mature vertebrate pancreas
(Serrano et al., 1989; Pérez-Villamil et al., 1994), but can be clearly
detected in the chick embryo during gastrulation and neurulation
(Morales et al., 1997) and in the embryonic retinal neuroepithe-
lium at E3 (Díaz et al., 1999). Proinsulin protein, as detected
with anti-C peptide antibody, is present in discrete cells located
in the three embryonic layers of the chick embryo, though mainly
in the neuroepithelium, prior to IGF-1 expression (Hernández-
Sánchez et al., 2002). In contrast with the pancreatic transcripts,
embryonic proinsulin mRNA levels are not regulated by glucose
(Pérez-Villamil et al., 1994), suggesting that alternative mecha-
nisms of regulation are operative in early embryos. As described
above, an alternative transcription start site exists in neurulat-
ing chick embryos (generating transcript Pro1B), and retention of
intron 1 occurs in another embryonic form of proinsulin embry-
onic mRNA (Pro1B1). These features impact on the respective
translational levels (Figure 3C; Hernández-Sánchez et al., 2003;
Mansilla et al., 2005). An example of the modulation of the proin-
sulin splicing pattern in chick embryos undergoing neurulation
and early organogenesis is shown in Figure 3B. Proinsulin intron
1 was efﬁciently spliced out in the optic vesicle, but retained in the
heart tube and presomitic region. The developing eye, therefore,
displays a translationally more active form of proinsulin mRNA
than other embryo regions, at a time when the IR is expressed and
active (Girbau et al., 1989). The role of proinsulin during early
stages of neural development is discussed below.
DISTINCT ACTIONS OF PROINSULIN IN THE DEVELOPING
NERVOUS SYSTEM
The study of a possible physiological function of proinsulin in ver-
tebrates has been hindered by both the essential metabolic role of
its processed product, the insulin hormone, and the classiﬁcation
of IGF-1 and IGF-2 as the “genuine growth factors” of the family.
However, the phylogenic and ontogenic expression data presented
above support a role for proinsulin as a growth factor in its own
right.
The roles of IGF-1 in nervous system have been extensively
characterized and include, among others, neuroprotection during
development and in the adult brain (D’Ercole andYe, 2008; Torres-
Aleman, 2010). Moreover, the physiological actions of insulin in
the nervous system, previously considered an insulin-insensitive
tissue, are increasingly recognized, particularly at the level of
synapse development and plasticity (Abbott et al., 1999; Chiu and
Cline, 2010). However, recent studies have revealed that insulin
and IGF-1 are not the only members of this family of physiological
factors active in early developmental stages.
A key aspect of putative proinsulin action involves receptor
availability. The classical composition of this tyrosine kinase recep-
tor consists of a homodimeric α2β2 entity resulting from the
post-translational cleavage of a single protein product into two
subunits, α and β. Both subunits are then covalently re-bound by
a disulﬁde bond to form a monomer, and two monomers in turn
covalently bound by two disulﬁde bonds between the α subunits
form a homodimeric receptor. An extensive review of the receptor
gene and protein structure has been recently published (Belﬁore
et al., 2009). Classical IRs display a reduced afﬁnity for proinsulin,
about one order of magnitude lower than that of insulin. Simi-
larly, classical IGFRs cannot bind physiological concentrations of
proinsulin (DePablo et al., 1990).However, in the embryonic chick
neuroretina at early proliferative stages, proinsulin-mediated sig-
naling appears to occur through an atypical,promiscuous receptor,
which is also activated by insulin and IGF-1 (García-de Lacoba
et al., 1999). It should be noted that, at the ligand level, proinsulin
appears to be the main factor present at this developmental stage.
Without distinguishing between proinsulin and insulin, insulin-
like immunoreactivity in the vitreous humor ﬁlling the chick
embryonic eye is 100 times higher than IGF-1-like immunore-
activity (Hernández-Sánchez et al., 1995). Moreover, when
immunoblot analysis was performed, the only identiﬁed product
present in the neurulating chick embryo and embryonic retina was
proinsulin (Alarcón et al., 1998; Hernández-Sánchez et al., 2002).
It is possible that proinsulin binds to a hybrid receptor in the
embryonic chick retina, composed of an αβ monomer of the IR
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and a αβ monomer of the IGFR.While such receptors are found in
the early embryonic retina, when proinsulin is active, their pres-
ence decreases as the retina matures. In parallel, homodimeric IRs
become more abundant, and proinsulin less active, with retinal
maturation (García-de Lacoba et al., 1999). The situation is even
more complex in mammals, where the IR contains an additional,
11th exon (called IR-B), which is spliced out in fetal, and non-
metabolic tissues. IR lacking exon 11 (IR-A form) also display
a promiscuous binding capacity, particularly for IGF-2 (Belﬁore
et al., 2009; Chiu and Cline, 2010), though its afﬁnity for proin-
sulin remains to be determined. Furthermore, the presence of
three hybrid receptors, IR-A/IR-B, IR-A/IGFR, and IR-B/IGFR is
suspected in different tissues, particularly in the nervous system
and in transformed cells, suggesting a complex interplay between
possible ligands and cellular effects (Belﬁore et al., 2009).
Proinsulin promotes cell proliferation, differentiation, and
survival in the embryonic chick and mouse nervous system
(Hernández-Sánchez et al., 1995;Díaz et al., 1999,2000;Valenciano
et al., 2006). Its primary role, however, appears to be the regulation
of cell survival during early neural development under normal
conditions, resulting in increased numbers of proliferating neu-
roepithelial cells or neurons. Conversely, blocking antibodies tar-
geting the IR induce apoptosis in the early chick retina, decreasing
neuronal numbers (Figure 4; Díaz et al., 2000). A similar apoptotic
FIGURE 4 | Interference with the insulin receptor increases cell death
and decreases the number of retinal ganglion cell neurons in the
embryonic chick retina. E2 chick embryos were treated in vivo with
control or anti-insulin receptor antibodies. TUNEL-positive cells [in green
(A,B)] were visualized in E4 ﬂat-mount retinas. Optic ﬁbers were labeled by
G4/Ng-CAM immunostaining (in red). Retinal ganglion cells were visualized
by Islet 1/2 immunostaining [in green (C,D)] in E6 retinal sections.
Reproduced from Díaz et al. (2000) with permission; ©2000, Company of
Biologists. Scale bar=50μm.
effect is observed when antisense oligonucleotides targeting the
IR are used to interfere with proinsulin signaling (Hernández-
Sánchez et al., 2002). Treatment with exogenous proinsulin in
ovo results in a decrease in naturally occurring apoptosis and
leads to developmental abnormalities in the neural tube and
optic vesicles, indicating that controlled regulation of proinsulin
expression and function is crucial for proper neural development
(Hernández-Sánchez et al., 2003).
OTHER PHYSIOLOGICAL AND PATHOLOGICAL NEURAL
PROCESSES DEPENDENT UPON IR-SIGNALING
As stated earlier, growing evidence has described several insulin
actions in tissues previously considered insulin-insensitive (Ogg
et al., 2005). Given the lack of studies of proinsulin expression
and binding capacity, together with promiscuity of the receptors
involved, it is plausible that some of the actions described for
insulin and IGF-1 may be in fact mediated by either physiological
or reactive to disease proinsulin activity. One such example is the
effect of proinsulin in attenuating pathological cell death in the
retina in a murine model of retinal dystrophy. The rd 10 mouse
is a model of human retinitis pigmentosa. One-month-old rd 10
mice are almost blind due to a degenerative process that involves
apoptosis of the photoreceptor cells in the retina (Barhoum et al.,
2008). Transgenic expression of human proinsulin delays vision
loss, a phenomenon that correlates with decreased cell death and
the preservation of the photoreceptor layer with more rods and
cones, and better synaptic connections (Figure 5; Corrochano
FIGURE 5 | Photoreceptor cell death is delayed and the photoreceptor
layer is preserved in rd10 mice expressing proinsulin. Cell death was
visualized byTUNEL in P25 ﬂat-mount retinas of rd10 and hPi/rd10
transgenic mice [in green (A,B)]. Retinal cytoarchitecture was visualized
with Alexa 488-peanut agglutinin [green-labeled cones (C,D)] and DAPI
staining [blue (C,D); arrow indicates photoreceptor rows] in P32 retinal
sections. Reproduced from Corrochano et al. (2008) with permission;
©2008, The Association for Research in Vision and Ophthalmology. Scale
bars=200μm in (A,B) and 25μm in (C,D).
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et al., 2008). Clearly, proinsulin can activate cellular processes in
the dystrophic retina, though the receptors involved remain to be
identiﬁed.
Physiological and pathological aging, as well as life span, are
other processes potentially modulated by the activity of proin-
sulin (see for a reviewTaguchi andWhite, 2008). Although initially
related to IGF-1 signaling, several observations have implicated
insulin sensitivity in longevity, while insulin resistance appears to
be a feature of neurodegenerative disorders, including Alzheimer’s
disease, Parkinson’s disease, and Lewy body dementia (Schubert
et al., 2004; Messier and Teutenberg, 2005; Steen et al., 2005; Zhao
et al., 2008; Tong et al., 2009). Furthermore, synapse formation and
maintenance mediated by IR signaling, particularly via the PI3K
pathway, may contribute to brain function in both normal and
physiological conditions in invertebrates and vertebrates (Martín-
Peña et al., 2006; Arendt et al., 2010; Chiu and Cline, 2010). While
thenature of the proinsulin receptor involved and the levels of local
proinsulin synthesis remain undetermined, it should be noted that
PI3K inhibition abolishes the pro-survival effects of proinsulin in
the developing retina (Valenciano et al., 2006).
PERSPECTIVES FOR FUTURE STUDIES AND USES OF
PROINSULIN
The role of proinsulin, beyond its prohormone function, as a gen-
uine cell survival or tissue growth factor has remained overlooked
for half a century. The observations reviewed here encourage
future studies to characterize proinsulin expression at the pro-
tein level in the developing and adult nervous systems, not only
under physiological conditions but also during aging and patho-
logical processes. Particularly, the receptor entities able to bind
proinsulin in mammals need to be identiﬁed, as a requisite to
fully elucidate the physiological relevance of proinsulin, as well as
its potential pharmacological use in insulin-resistance conditions
or diseases with abnormally increased cell death. The dramatic
impact of diabetes and neurodegenerative disorders on our soci-
ety further highlights the need for new therapeutic strategies
that may relay on various factors of the insulin family, to treat
these conditions. There are, to our knowledge, no clinical trials
presently underway with proinsulin. Indeed, preclinical studies in
animal models of retinitis pigmentosa with proinsulin treatment,
commented here, are the initial step toward future therapeutical
developments.
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